Telomir Pharmaceuticals TELO Ratios (2023-2026)

NASDAQ TELO
$1.02 +0.01 (+1.49%)
As of: Oct 21, 2026 · 1:41 PM EDT
Reported Financials

Telomir Pharmaceuticals Quarterly Ratios

Periods 13 quarters
Latest Jun 2026

Telomir Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 13 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Profitability
Net Margin -5,448.57%-38,787.52%-27,405.43%-23,044,954.55%-2,494.89%
FCF Margin -5,973.57%-6,489.88%-11,315.06%-2,998,077.27%-2,128.52%
Efficiency
Assets AverageAssets Avg. 4.14M2.80M1.57M1.18M0.91M0.66M4.12M7.37M6.35M
Equity AverageEquity Avg. -0.72M1.69M3.03M2.81M3.23M2.32M1.03M0.54M0.24M0.16M3.73M6.45M5.47M
Invested CapitalInvested Cap. 3.54M5.17M
Asset Utilization RatioAsset Util. -4.730.070.02
Leverage & Solvency
Debt Ratio 0.020.03
Valuation
Price to SalesP/S 779.79695.61
Price to BookP/B 50.5587.51430.01190.6979.266.747.7317.49
Enterprise Value 149.19M140.52M189.26M121.36M95.73M37.39M39.70M38.44M82.83M
Market Capitalization 152.49M142.42M190.10M122.62M96.13M38.14M47.03M45.73M88.03M

Telomir Pharmaceuticals Ratios API

Pull Telomir Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TELO&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY